News & Events about Stockal+Disclaimer.pdf.
Abbott Receives FDA Approval for World's First Dual-Chamber Leadless Pacemaker Abbott Receives FDA Approval for World's First Dual-Chamber Leadless Pacemaker PR Newswire ABBOTT PARK, Ill., July 5, 2023 Abbott's breakthrough technology enables the world's first beat-to-beat, wireless communication...
Abbott Hosts Conference Call for Second-Quarter Earnings Abbott Hosts Conference Call for Second-Quarter Earnings PR Newswire ABBOTT PARK, Ill., June 29, 2023 ABBOTT PARK, Ill., June 29, 2023 /PRNewswire/ -- Abbott (NYSE: ABT) will announce its second-quarter 2023 financial results on Thursday...
ARLINGTON, VA and ABBOTT PARK, IL / ACCESSWIRE / June 28, 2023 / Abbott:AbbottOn June 24, the American Diabetes Association® (ADA) and Abbott announced a collaboration aimed at better understanding how diabetes technology like continuous glucose monitoring (CGM) systems can help people...
Ticker Report
10 months ago
Valeo Financial Advisors LLC raised its position in shares of Abbott Laboratories (NYSE:ABT Get Rating) by 7.2% during the 1st quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 26,396 shares of the healthcare ...
Ticker Report
10 months ago
Hills Bank Trust Co increased its stake in shares of Abbott Laboratories (NYSE:ABT Get Rating) by 1.8% in the first quarter, according to the company in its most recent Form 13F filing with the Securities Exchange Commission. The firm owned 43,296 shares of the healthcare product...